Novo Integrated Sciences, Inc.
NVOS · OTC
8/31/2024 | 8/31/2023 | 8/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Revenue | $13 | $13 | $12 | $9 |
| % Growth | 5.7% | 7.1% | 26.1% | – |
| Cost of Goods Sold | $8 | $8 | $7 | $5 |
| Gross Profit | $6 | $5 | $5 | $4 |
| % Margin | 43.2% | 39.4% | 40.9% | 41.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $14 | $13 | $14 | $8 |
| SG&A Expenses | $14 | $14 | $14 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $14 | $14 | $14 | $8 |
| Operating Income | -$8 | -$9 | -$10 | -$4 |
| % Margin | -62.5% | -68% | -81.7% | -45.9% |
| Other Income/Exp. Net | -$8 | -$5 | -$23 | -$0 |
| Pre-Tax Income | -$16 | -$13 | -$33 | -$4 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$16 | -$13 | -$33 | -$4 |
| % Margin | -121.3% | -105.1% | -279.9% | -48% |
| EPS | -0.9 | -1.3 | -11.28 | -1.8 |
| % Growth | 30.8% | 88.5% | -526.7% | – |
| EPS Diluted | -0.9 | -1.3 | -11.28 | -1.8 |
| Weighted Avg Shares Out | 18 | 10 | 3 | 2 |
| Weighted Avg Shares Out Dil | 18 | 10 | 3 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$1 | $5 | $8 | $0 |
| Depreciation & Amortization | $7 | $2 | $3 | $2 |
| EBITDA | -$10 | -$6 | -$22 | -$3 |
| % Margin | -75.8% | -46.5% | -191.5% | -27.7% |